These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31570385)

  • 21. "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.
    Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
    Int J Equity Health; 2021 Mar; 20(1):81. PubMed ID: 33740984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of hepatitis C virus infection.
    Roudot-Thoraval F
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101596. PubMed ID: 33610022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
    Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
    Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
    Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
    Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
    Hajarizadeh B; Grebely J; Martinello M; Matthews GV; Lloyd AR; Dore GJ
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):317-327. PubMed ID: 28404202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?
    Martin NK; Boerekamps A; Hill AM; Rijnders BJA
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25062. PubMed ID: 29633560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment of chronic hepatitis C in China: Dilemma and potential problems.
    Han QY; Liu ZW
    World J Gastroenterol; 2016 May; 22(19):4615-8. PubMed ID: 27217693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to manage hepatitis C virus infection disease burden-Volume 4.
    Chen DS; Hamoudi W; Mustapha B; Layden J; Nersesov A; Reic T; Garcia V; Rios C; Mateva L; Njoya O; Al-Busafi SA; Abdelmageed MK; Abdulla M; Adda D; Akin O; Al Baqali A; Al Dweik N; Al Ejji K; Al Ghazzawi I; Al Kaabi S; Al Naamani K; Al Qamish J; Al Sadadi M; Al Salman J; AlBadri M; Al-Romaihi HE; Ampofo W; Antonov K; Anyaike C; Arome F; Bane A; Blach S; Borodo MM; Brandon SM; Bright B; Butt MT; Cardenas I; Chan HLY; Chen CJ; Chen PJ; Chien RN; Chuang WL; Cuellar D; Derbala M; Elbardiny AA; Estes C; Farag E; Fung J; Gamkrelidze I; Genov J; Ghandour Z; Ghuloom M; Gomez B; Gunter J; Habeeb J; Hajelssedig O; Himatt SM; Hrstic I; Hu CC; Huang CF; Hui YT; Jahis R; Jelev D; John AK; Kaliaskarova KS; Kamel Y; Kao JH; Khamis J; Khattabi H; Khoudri I; Konysbekova A; Kotzev I; Lai MS; Lao WC; Lee MH; Lesi O; Li M; Lo A; Loo CK; Lukšić B; Maaroufi A; Malu AO; Mitova R; Mohamed R; Morović M; Murphy K; Nde H; Ngige E; Njouom R; Nonković D; Obekpa S; Oguche S; Okolo EE; Omede O; Omuemu C; Ondoa P; Opare-Sem O; Owusu-Ofori S; Phillips RO; Prokopenko YN; Razavi H; Razavi-Shearer D; Razavi-Shearer K; Redae B; Rinke de Wit T; Robbins S; Roberts LR; Sanad SJ; Sharma M; Simonova M; Su TH; Sultan K; Tan SS; Tchernev K; Tsang OTY; Tsang S; Tzeuton C; Ugoeze S; Uzochukwu B; Vi R; Vince A; Wani HU; Wong VWS; Workneh A; Yacoub R; Yesmembetov KI; Youbi M; Yuen MF; Schmelzer JD
    J Viral Hepat; 2017 Oct; 24 Suppl 2():44-63. PubMed ID: 29105286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Planning the hepatitis C virus elimination in Cyprus: A modeling study.
    Gountas I; Yiasemi I; Kyprianou E; Mina C; Georgiou C; Katsioloudes P; Kouroufexi A; Demetriou A; Xenofontos E; Nikolopoulos G
    World J Gastroenterol; 2021 Aug; 27(31):5219-5231. PubMed ID: 34497446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of hepatitis C in Europe: can WHO targets be achieved?
    Matičič M; Lombardi A; Mondelli MU; Colombo M;
    Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.
    Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ;
    Int J Drug Policy; 2017 Sep; 47():51-60. PubMed ID: 28683982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hepatitis B and C in children.
    El-Shabrawi M; Hassanin F
    Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.
    Marshall AD; Cunningham EB; Nielsen S; Aghemo A; Alho H; Backmund M; Bruggmann P; Dalgard O; Seguin-Devaux C; Flisiak R; Foster GR; Gheorghe L; Goldberg D; Goulis I; Hickman M; Hoffmann P; Jancorienė L; Jarcuska P; Kåberg M; Kostrikis LG; Makara M; Maimets M; Marinho RT; Matičič M; Norris S; Ólafsson S; Øvrehus A; Pawlotsky JM; Pocock J; Robaeys G; Roncero C; Simonova M; Sperl J; Tait M; Tolmane I; Tomaselli S; van der Valk M; Vince A; Dore GJ; Lazarus JV; Grebely J;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):125-133. PubMed ID: 28986139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high-prevalence setting?
    Gountas I; Sypsa V; Anagnostou O; Martin N; Vickerman P; Kafetzopoulos E; Hatzakis A
    Addiction; 2017 Jul; 112(7):1290-1299. PubMed ID: 28107585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis.
    Yousafzai MT; Bajis S; Alavi M; Grebely J; Dore GJ; Hajarizadeh B
    J Viral Hepat; 2021 Oct; 28(10):1340-1354. PubMed ID: 34310812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.